Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics

Vekemans, Johan; Moorthy, Vasee; Friede, Martin; Alderson, Mark R.; Sobanjo-Ter Meulen, Ajoke; Baker, Carol J.; Heath, Paul T.; Madhi, Shabir A.; Mehring-Le Doare, Kirsty; Saha, Samir K.; Schrag, Stephanie; Kaslow, David C.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics

February 02 2018
By Vekemans, Johan ; Moorthy, Vasee ; Friede, Martin ; ...
Source: Vaccine. 2017; 37(50):7391-7393

[PDF-901.98 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Vaccine
Personal Author:

Vekemans, Johan ; Moorthy, Vasee ; Friede, Martin ; Alderson, Mark R. ; Sobanjo-Ter Meulen, Ajoke ; ... More +

Vekemans, Johan ; Moorthy, Vasee ; Friede, Martin ; Alderson, Mark R. ; Sobanjo-Ter Meulen, Ajoke ; Baker, Carol J. ; Heath, Paul T. ; Madhi, Shabir A. ; Mehring-Le Doare, Kirsty ; Saha, Samir K. ; Schrag, Stephanie ; Kaslow, David C. Less -
Description:

Group B streptococcus, found in the vagina or lower gastrointestinal tract of about 10-40% of women of reproductive age, is a leading cause of early life invasive bacterial disease, potentially amenable to prevention through maternal immunization during pregnancy. Following a consultation process with global stakeholders, the World Health Organization is herein proposing priority research and development pathways and preferred product characteristics for GBS vaccines, with the aim to facilitate and accelerate vaccine licensure, policy recommendation for wide scale use and implementation.
Subjects:

[+]

Article Group B Streptococcus Maternal Immunization Vaccine
Source:

Vaccine. 2017; 37(50):7391-7393
Pubmed ID:

29398277
Pubmed Central ID:

PMC6892248
Document Type:

Journal Article
Funding:

001/WHO_/World Health Organization/International
Volume:

37
Issue:

50
Collection(s):

CDC Public Access
Main Document Checksum:

[+]

urn:sha256:097b498e4d5338c32ec63ff7598949dbd40f3299e5c2297e2690abf665c355ac
Download URL:

https://stacks.cdc.gov/view/cdc/89270/cdc_89270_DS1.pdf
File Type:

	gr1_lrg.gif	gif
	gr1_lrg.jpg	jpeg
	gr2_lrg.gif	gif
	gr2_lrg.jpg	jpeg
	gr3_lrg.gif	gif
	gr3_lrg.jpg	jpeg
	main.nxml	xml
	mmc1.docx	docx

More +